PENG Block Optimization: Volume and Dexamethasone Effects

NCT07023120 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hip Arthropathy
Hip Osteoarthritis
Hip Arthritis

Interventions

DRUG: Ropivacaine 0.2% Injectable Solution
DRUG: Dexamethasone 4mg
DRUG: Ropivacaine 0.2% Injectable Solution

Sponsor

Poznan University of Medical Sciences